Introduction The landscape of gynecologic oncology is undergoing a paradigm shift driven by the emergence of next-generation antibody-drug conjugates (ADCs). Says Dr. Scott Kamelle, historically, patients
Introduction Ovarian cancer remains one of the most challenging gynecologic malignancies to treat effectively due to its high propensity for recurrence and the frequent development
Introduction to the Immunotherapy Paradigm Shift The landscape of gynecologic oncology has undergone a transformative shift in recent years, particularly regarding the management of uterine
Introduction The landscape of gynecological oncology is undergoing a transformative shift as artificial intelligence integrates with molecular diagnostics to redefine early cancer detection. Ovarian and
Introduction to Precision Oncology The management of ovarian cancer has historically relied on a “one-size-fits-all” approach, typically involving cytoreductive surgery followed by platinum-based chemotherapy. While
Introduction: The Dawn of Epigenetic Oncology The landscape of gynecological oncology is undergoing a profound transformation as researchers shift their focus from traditional genetic mutations
Introduction: The Dawn of Precision Gynecology The landscape of uterine medicine is undergoing a profound transformation as traditional, one-size-fits-all diagnostic models give way to highly
Introduction Ovarian carcinoma remains one of the most lethal gynecological malignancies, primarily due to its propensity for late-stage diagnosis. The absence of specific symptoms during
Introduction Recurrent gynecologic malignancies, including cervical, uterine, and vaginal cancers, represent a significant challenge in oncology. Despite advancements in surgical techniques and chemotherapy, recurrence remains
Introduction: A Growing Challenge – The Rise of Platinum-Resistant Ovarian Cancer Ovarian cancer remains a significant and challenging disease, impacting millions of women worldwide. While